These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 27000226)

  • 41. Survival and low-grade glioma: the emergence of genetic information.
    Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
    Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients.
    Xu T; Qin R; Zhou J; Yan Y; Lu Y; Zhang X; Fu D; Lv Z; Li W; Xia C; Hu G; Ding X; Chen J
    PLoS One; 2012; 7(10):e48415. PubMed ID: 23119009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of microRNA-10b upregulation and poor prognosis in human gliomas.
    Ji Y; Wei Y; Wang J; Gong K; Zhang Y; Zuo H
    Tumour Biol; 2015 Aug; 36(8):6249-54. PubMed ID: 25773393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Prognostication Potential of BRCA Genes Expression in Gliomas: A Genetic Survival Analysis Study.
    Meimand SE; Pour-Rashidi A; Shahrbabak MM; Mohammadi E; Meimand FE; Rezaei N
    World Neurosurg; 2022 Jan; 157():e123-e128. PubMed ID: 34607064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of TELO2 decreases survival in human high-grade gliomas.
    Feng SW; Chen Y; Tsai WC; Chiou HC; Wu ST; Huang LC; Lin C; Hsieh CC; Yang YJ; Hueng DY
    Oncotarget; 2016 Jul; 7(29):46056-46066. PubMed ID: 27329594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of microRNA-372 upregulation with poor prognosis in human glioma.
    Li G; Zhang Z; Tu Y; Jin T; Liang H; Cui G; He S; Gao G
    Diagn Pathol; 2013 Jan; 8():1. PubMed ID: 23298385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
    Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
    Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between downexpression of miR-1301 and poor prognosis in patients with glioma.
    Bai QL; Hu CW; Wang XR; Yin GF; Shang JX
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4298-4303. PubMed ID: 29077167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CPEB4 interacts with Vimentin and involves in progressive features and poor prognosis of patients with astrocytic tumors.
    Chen W; Hu Z; Li XZ; Li JL; Xu XK; Li HG; Liu Y; Liu BH; Jia WH; Li FC
    Tumour Biol; 2016 Apr; 37(4):5075-87. PubMed ID: 26546435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-599 as a potential biomarker for prognosis of glioma.
    Zhu XY; Li GX; Liu ZL
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):294-298. PubMed ID: 29424886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma.
    Wang S; Lu S; Geng S; Ma S; Liang Z; Jiao B
    Med Oncol; 2013 Mar; 30(1):373. PubMed ID: 23292865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma.
    Ryall S; Krishnatry R; Arnoldo A; Buczkowicz P; Mistry M; Siddaway R; Ling C; Pajovic S; Yu M; Rubin JB; Hukin J; Steinbok P; Bartels U; Bouffet E; Tabori U; Hawkins C
    Acta Neuropathol Commun; 2016 Aug; 4(1):93. PubMed ID: 27577993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Slit2 and Robo1 expression as biomarkers for assessing prognosis in brain glioma patients.
    Liu L; Li W; Geng S; Fang Y; Sun Z; Hu H; Liang Z; Yan Z
    Surg Oncol; 2016 Dec; 25(4):405-410. PubMed ID: 27916173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overall survival in patients with malignant glioma may be significantly longer with tumors located in deep grey matter.
    Ramnarayan R; Dodd S; Das K; Heidecke V; Rainov NG
    J Neurol Sci; 2007 Sep; 260(1-2):49-56. PubMed ID: 17475281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
    Lin L; Wang G; Ming J; Meng X; Han B; Sun B; Cai J; Jiang C
    Tumour Biol; 2016 Nov; 37(11):15333-15339. PubMed ID: 27704357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of microRNA-205 as a potential prognostic indicator for human glioma.
    Hou SX; Ding BJ; Li HZ; Wang L; Xia F; Du F; Liu LJ; Liu YH; Liu XD; Jia JF; Li L; Wu ZL; Zhao G; Zhang ZG; Deng YC
    J Clin Neurosci; 2013 Jul; 20(7):933-7. PubMed ID: 23683741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance.
    Chen XD; Zhu MX; Wang SJ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3455-3460. PubMed ID: 31081100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma.
    Zhou Y; Wang DL; Pang Q
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3035-9. PubMed ID: 27460732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated E2F7 expression predicts poor prognosis in human patients with gliomas.
    Yin W; Wang B; Ding M; Huo Y; Hu H; Cai R; Zhou T; Gao Z; Wang Z; Chen D
    J Clin Neurosci; 2016 Nov; 33():187-193. PubMed ID: 27460513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance.
    Wang L; Wu L; Wu J
    J Int Med Res; 2016 Oct; 44(5):994-1001. PubMed ID: 27417886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.